Functional plasticity of macrophages: in situ reprogramming of tumor‐associated macrophages
暂无分享,去创建一个
[1] S. Masli,et al. Anti‐inflammatory effects of tumour necrosis factor (TNF)‐α are mediated via TNF‐R2 (p75) in tolerogenic transforming growth factor‐β‐treated antigen‐presenting cells , 2009, Immunology.
[2] Lionel B Ivashkiv,et al. Cross-regulation of signaling by ITAM-associated receptors , 2009, Nature Immunology.
[3] Vishva Dixit,et al. Death receptor signal transducers: nodes of coordination in immune signaling networks , 2009, Nature Immunology.
[4] J. Suttles,et al. Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.
[5] R. Apte,et al. Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development , 2008, PloS one.
[6] A. M. Houghton,et al. Common origins of lung cancer and COPD , 2008, Nature Medicine.
[7] M. Mack,et al. Glucocorticoids induce an activated, anti‐inflammatory monocyte subset in mice that resembles myeloid‐derived suppressor cells , 2008, Journal of leukocyte biology.
[8] R. Ádány,et al. Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.
[9] J. O’Shea,et al. Cytokine signaling modules in inflammatory responses. , 2008, Immunity.
[10] I. Wang,et al. Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. , 2008, American journal of respiratory cell and molecular biology.
[11] James A. Hutchinson,et al. Macrophages Driven to a Novel State of Activation Have Anti-Inflammatory Properties in Mice1 , 2008, The Journal of Immunology.
[12] E. Benveniste,et al. Type I Interferons as Anti-Inflammatory Mediators , 2007, Science's STKE.
[13] C. Elson,et al. Molecular Mechanism of Lipopolysaccharide-Induced SOCS-3 Gene Expression in Macrophages and Microglia1 , 2007, The Journal of Immunology.
[14] B. Graham-Evans,et al. TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. , 2007, Blood.
[15] L. Ivashkiv,et al. Crosstalk among Jak‐STAT, Toll‐like receptor, and ITAM‐dependent pathways in macrophage activation , 2007, Journal of leukocyte biology.
[16] D. Greenhalgh,et al. Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.
[17] G. Parmiani,et al. Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.
[18] J. Suttles,et al. IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo1 , 2007, The Journal of Immunology.
[19] Yu-Tseung Liu,et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.
[20] Jun Kawai,et al. Alternate transcription of the Toll-like receptor signaling cascade , 2006, Genome Biology.
[21] Paolo Serafini,et al. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.
[22] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[23] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[24] A. Rakhmilevich,et al. Synergistic Activation of Macrophages via CD40 and TLR9 Results in T Cell Independent Antitumor Effects1 , 2006, The Journal of Immunology.
[25] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[26] D. Dormont,et al. Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.
[27] S. Meijer,et al. The Role of Macrophages in Tumor Development , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[28] R. Jope,et al. Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.
[29] J. Suttles,et al. Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.
[30] J. Suttles,et al. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age‐associated microenvironmental changes , 2005, Immunological reviews.
[31] A. Rakhmilevich,et al. CD40 Ligation Activates Murine Macrophages via an IFN-γ-Dependent Mechanism Resulting in Tumor Cell Destruction In Vitro 1 , 2005, The Journal of Immunology.
[32] G. Trinchieri,et al. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. , 2005, Cancer research.
[33] J. Utikal,et al. Interleukin‐4 and Dexamethasone Counterregulate Extracellular Matrix Remodelling and Phagocytosis in Type‐2 Macrophages , 2005, Scandinavian journal of immunology.
[34] J. Suttles,et al. Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.
[35] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[36] B. Brew,et al. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification , 2004, Journal of leukocyte biology.
[37] P. Barnes. Alveolar Macrophages as Orchestrators of COPD , 2004, COPD.
[38] M. Fenton,et al. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. , 2003, Molecular interventions.
[39] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[40] M. Sabel,et al. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. , 2002, Cancer research.
[41] P. Finan,et al. IL‐10 expression profiling in human monocytes , 2002, Journal of leukocyte biology.
[42] J. Norton,et al. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. , 2002, Cancer research.
[43] Peter J. Murray,et al. Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.
[44] D. Laskin,et al. Functional heterogeneity in liver and lung macrophages , 2001, Journal of leukocyte biology.
[45] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[46] Constantin E. Orfanos,et al. Alternative versus Classical Activation of Macrophages , 2000, Pathobiology.
[47] D. Mullins,et al. Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.
[48] D. Chaussabel,et al. IL‐10 up‐regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)‐activated macrophages: improved control of Trypanosoma cruzi infection , 1998, Clinical and experimental immunology.
[49] Yoshiyuki Niho,et al. Role of IL-10 in the Crossregulation of Prostaglandins and Cytokines in Monocytes , 1998, Acta Haematologica.
[50] G. Trinchieri,et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. , 1998, The Journal of clinical investigation.
[51] B. Becher,et al. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia , 1996, Glia.
[52] J. Suttles,et al. T-Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals , 1995 .
[53] G. Trinchieri,et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production , 1995, The Journal of experimental medicine.
[54] L. Luistro,et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.
[55] C. Nathan,et al. Modulation of Macrophage Function by Transforming Growth Factor β, Interleukin‐4, and Interleukin‐10 a , 1993, Annals of the New York Academy of Sciences.
[56] Jelena S. Bezbradica,et al. Integration of cytokine and heterologous receptor signaling pathways , 2009, Nature Immunology.
[57] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[58] E. Raz. Organ-specific regulation of innate immunity , 2007, Nature Immunology.
[59] R. Diegelmann,et al. Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.
[60] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[61] C. Haslett,et al. MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation , 2003 .
[62] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[63] R. Schreiber. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity. , 1984, Contemporary topics in immunobiology.